欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0623/001
药品名称Atosiban EVER Pharma 6.75 mg/0.9 ml solution for injection
活性成分
    • atosiban acetate 6.75 mg/0,9 ml
剂型Solution for injection
上市许可持有人EVER Neuro Pharma GmbH Oberburgau 3 4866 Unterach am Attersee Austria
参考成员国 - 产品名称Austria (AT)
Atosiban EVER Pharma 6,75 mg/0,9 ml Injektionslösung
互认成员国 - 产品名称
    • Germany (DE)
      Atosiban EVER Pharma 6,75 mg/0.9 ml Injektionslösung
    • Denmark (DK)
    • Belgium (BE)
      Atosiban EVER Pharma 6,75 mg/0,9 ml oplossing voor injectie
    • Netherlands (NL)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • United Kingdom (Northern Ireland) (XI)
    • Sweden (SE)
    • Norway (NO)
      Atosiban EVER Pharma
    • Finland (FI)
    • Poland (PL)
      Atosiban Ever Pharma
    • Czechia (CZ)
      Atosiban EVER Pharma 6,75mg/0,9 ml injekční roztok
许可日期2016/09/01
最近更新日期2023/09/22
药物ATC编码
    • G02CX01 atosiban
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase